Trevena Inc. (TRVN) - Pendapatan lan volume dodolan
The development of analgesics is independent of GDP, providing resilience against macro shocks for Trevena, Inc. (TRVN). The scientific team is motivated by the creation of safe CNS drugs. Sales figures for the company are available in the GURU.Markets system, where the 0.00 indicator expresses the state of the metric. However, FDA regulatory bans on opioids and commercial failures weakened patent protection, which led the business to delisting.
Rincian metrik komprehensif lan analitis Trevena Inc (TRVN)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- rincian nilai buku perusahaan:
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas Trevena, Inc.|TRVN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Trevena, Inc.|TRVN - Gunggung utang perusahaan|Utang-utang marang aset resik Trevena Inc|TRVN - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Trevena|Rasio jangkoan perantara trevena.com
- indikator bathi lan kelipatan valuasi:
TRVN - Penghasilan resik|Bathi sing dikarepake Trevena, Inc.|TRVN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Trevena Inc.|TRVN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Trevena Inc.|TRVN - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Trevena|TRVN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan trevena.com|TRVN - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Trevena, Inc.
- statistik dodolan lan pendapatan perusahaan:
Analisis umum perusahaan:Trevena, Inc.
Efficient logistics for neurological drugs and the diversification of sales channels at Trevena, Inc. (TRVN) translate directly into revenue dynamics, reflecting a genuine expansion of its commercial footprint. Daily tracking of this metric allows investors to monitor fundamental business growth in real time, while the company's sales performance serves as an indicator of operational resilience and the issuer's ability to scale its market share.
Perusahaan pesaing
Volume dodolan perusahaan BIIB (Biogen)|Pendapatan perusahaan Neurocrine Biosciences, Inc. (NBIX)|Pendapatan perusahaan RGC (Regencell Bioscience Ltd)|Axsome Therapeutics, Inc. - Dodolan perusahaan|ACAD (ACADIA Pharmaceuticals Inc) - Pendapatan tahunan perusahaan|Xenon Corp - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Pendapatan perusahaan|Pendapatan tahunan perusahaan CPRX (Catalyst Pharmaceuticals, Inc.)|Pendapatan perusahaan Denali Therapeutics Inc|Total pendapatan perusahaan Harmony Corp HRMY|Pendapatan lan volume dodolan BHVN|Dodolan perusahaan Amylyx Pharmaceuticals AMLX|Pendapatan lan volume dodolan TRVI (Trevi Corp)|Pendapatan reged perusahaan Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Pendapatan lan volume dodolan|CeriBell Corp (CBLL) - Dodolan perusahaan|Prothena Corp (PRTA) - Pendapatan perusahaan|Total pendapatan perusahaan Alector Inc. (ALEC)|Dodolan perusahaan ANNX|omeros.com (OMER) - Pendapatan reged perusahaan|Pendapatan perusahaan Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan VYGR (voyagertherapeutics.com)|Pendapatan reged perusahaan Neumora Therapeutics (NMRA)|SCLX - Pendapatan perusahaan|Total volume dodolan perusahaan Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Pendapatan perusahaan|CGTX - Pendapatan reged perusahaan|IKT (inhibikase.com) - Pendapatan lan volume dodolan|cassavasciences.com (SAVA) - Pendapatan reged perusahaan|Dodolan perusahaan ASRT (Assertio Therapeutics)|Pendapatan reged perusahaan Coya Therapeutics|Vistagen - Dodolan perusahaan|ovidrx.com (OVID) - Total pendapatan perusahaan|Acumen Pharmaceuticals - Pendapatan lan volume dodolan|Total pendapatan perusahaan cervomed.com|ATHE: Pendapatan lan volume dodolan|Clene Inc - Pendapatan dodolan perusahaan|Pendapatan perusahaan PepGen|JUNS (Jupiter Neurosciences Inc) - Total dodolan perusahaan|Dodolan perusahaan RLMD (Relmada Corp)|annovisbio.com - Volume dodolan perusahaan|Pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan tahunan perusahaan|KLTO - Pendapatan perusahaan|Total pendapatan perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Pendapatan perusahaan|Volume dodolan perusahaan MTVA|Dodolan perusahaan NRXS|Dodolan perusahaan Helius Medical (HSDT)|Pendapatan lan volume dodolan PASG|Neuphoria Therapeutics - Volume dodolan perusahaan|Pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Pendapatan lan volume dodolan Athira Pharma ATHA|ADXN: Dodolan perusahaan|Total pendapatan perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Pendapatan perusahaan|Total pendapatan perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Pendapatan lan volume dodolan|Dodolan perusahaan Cortigent (CRGT)|Pendapatan lan volume dodolan ATXI|BCLI - Total pendapatan perusahaan|Pendapatan lan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Total pendapatan perusahaan|ELYM - Pendapatan perusahaan|Total volume dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan dodolan perusahaan|Dodolan perusahaan NKGN|NeuroBo - Pendapatan tahunan perusahaan|Pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Dodolan perusahaan Synaptogenix SNPX|Pendapatan perusahaan vigilneuro.com VIGL|Pendapatan reged perusahaan Anew Medical (WENA)|cerevel.com - Pendapatan lan volume dodolan
